Regeneron Pharmaceuticals (REGN)
Interest Expense
$55.40M
TTM · Period ending: · USD
REGN Interest Expense
Latest reported$55.40Mperiod ending
Latest reported$55.40Mperiod ending
REGN TTM Interest Expense ($0.00 → $55.40M)
TTM interest expense
High-resolution chart · PNG
REGN interest expense history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Interest Expense (USD) |
|---|---|
| 55,400,000 | |
| 48,000,000 | |
| 43,800,000 | |
| 42,100,000 | |
| 36,600,000 | |
| 47,800,000 | |
| 55,200,000 | |
| 63,000,000 | |
| 67,000,000 | |
| 71,100,000 | |
| 73,000,000 | |
| 72,100,000 | |
| 69,600,000 | |
| 63,800,000 | |
| 59,400,000 | |
| 56,100,000 | |
| 55,000,000 | |
| 56,300,000 | |
| 57,300,000 | |
| 58,000,000 | |
| 70,100,000 | |
| 65,400,000 | |
| 56,900,000 | |
| 48,800,000 | |
| 30,300,000 | |
| 28,600,000 | |
| 30,200,000 | |
| 30,849,000 | |
| 30,543,000 | |
| 29,461,000 | |
| 28,200,000 | |
| 26,886,000 | |
| 25,574,000 | |
| 24,057,000 | |
| 25,119,000 | |
| 22,478,000 | |
| 16,792,000 | |
| 13,564,000 | |
| 7,469,000 | |
| 7,684,000 | |
| 8,903,000 | |
| 9,478,000 | |
| 14,241,000 | |
| 16,982,000 | |
| 24,499,000 | |
| 31,928,000 | |
| 37,372,000 | |
| 42,683,000 | |
| 45,187,000 | |
| 46,375,000 | |
| 46,437,000 | |
| 46,271,000 | |
| 45,948,000 | |
| 45,819,000 | |
| 45,304,000 | |
| 43,264,000 | |
| 35,912,000 | |
| 28,723,000 | |
| 21,282,000 | |
| 14,285,000 | |
| 12,458,000 | |
| 10,753,000 | |
| 9,118,000 | |
| 8,416,000 | |
| 6,763,000 | |
| 4,421,000 | |
| 2,337,000 | |
| 12,803,000 | |
| 12,222,000 | |
| 14,896,000 | |
| 17,907,000 | |
| 5,685,000 | |
| 5,685,000 | |
| 3,011,000 | |
| 0 | |
| 0 | |
| 3,011,000 | |
| 3,011,000 | |
| 3,011,000 | |
| 3,011,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 7,092,000 |